CA
DNA icon

Clearstead Advisors’s Ginkgo Bioworks DNA Stock Holding History

Clearstead Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Hold
2
– – ﹤0.01% 2222
2025
Q4 		$17 Hold
2
– – ﹤0.01% 2698
2025
Q3 		$30 Sell
2
-500
-100% -$5.98K ﹤0.01% 3004
2025
Q2 		$5.65K Sell
502
-7
-1% -$54 ﹤0.01% 2071
2025
Q1 		$2.9K Hold
509
– – ﹤0.01% 1832
2024
Q4 		$5K Hold
509
– – ﹤0.01% 1719
2024
Q3 		$4.15K Sell
509
-1
-0.2% -$10 ﹤0.01% 1740
2024
Q2 		$6.82K Buy
510
+500
+5,000% +$14.9K ﹤0.01% 1625
2024
Q1 		$345 Buy
10
+2
+25% +$104 ﹤0.01% 1477
2023
Q4 		$507 Sell
8
-65
-89% -$3.98K ﹤0.01% 1461
2023
Q3 		$5.3K Buy
73
+67
+1,117% +$5.36K ﹤0.01% 1230
2023
Q2 		$465 Sell
6
-48
-89% -$2.84K ﹤0.01% 1305
2023
Q1 		$2.86K Hold
54
– – ﹤0.01% 1085
2022
Q4 		$3.63K Hold
54
– – ﹤0.01% 1019
2022
Q3 		$7K Hold
54
– – ﹤0.01% 928
2022
Q2 		$5K Hold
54
– – ﹤0.01% 996
2022
Q1 		$9K Buy
+54
New +$10.5K ﹤0.01% 997

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return